Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-04-30 Quart Barry D Chief Executive Officer Other acquisition +1,607 $13.22 $21K 69,600
2018-03-29 TANG KEVIN C Director Purchase +192,308 $26.00 $5.0M 8,525,215
2018-03-19 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion +18,000 $13.00 $234K 18,000
2018-03-19 MANHARD KIMBERLY Executive VP, Drug Development Sale −18,000 $30.00 $540K 0
2018-03-19 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion · Employee Stock Option (Right to Buy) −18,000 94,416
2018-03-19 Quart Barry D Chief Executive Officer Exercise or conversion +100,000 $7.20 $720K 167,993
2018-03-19 Quart Barry D Chief Executive Officer Sale −100,000 $29.75 $3.0M 67,993
2018-03-19 Quart Barry D Chief Executive Officer Exercise or conversion · Employee Stock Option (Right to Buy) −100,000 730,276
2018-03-14 Quart Barry D Chief Executive Officer Exercise or conversion +100,000 $7.20 $720K 167,993
2018-03-14 Quart Barry D Chief Executive Officer Sale −100,000 $24.75 $2.5M 67,993
2018-03-14 Quart Barry D Chief Executive Officer Exercise or conversion · Employee Stock Option(Right to Buy) −100,000 830,276
2018-01-10 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion +7,584 $13.00 $99K 7,584
2018-01-10 MANHARD KIMBERLY Executive VP, Drug Development Sale −7,584 $20.00 $152K 0
2018-01-10 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion · Employee Stock Option (Right to Buy) −7,584 112,416
2017-12-18 Christian Waage Director Grant or award · Stock Option (Right to Buy) +17,000 17,000
2017-12-18 POYHONEN JOHN Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2017-12-18 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2017-12-18 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +17,000 17,000
2017-12-18 Rosen Robert President Grant or award · Employee Stock Option (Right to Buy) +310,000 310,000
2017-12-18 Quart Barry D Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +310,000 310,000

Page 33 of 38 · 746 trades